An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers
Launched by WAYNE STATE UNIVERSITY · Sep 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special training program called neurofeedback, which aims to improve the overall well-being of mothers who have experienced trauma, especially those who have had difficult childhoods. The researchers want to see if this program helps these mothers manage their emotions better, reduces symptoms of post-traumatic stress disorder (PTSD), and positively impacts their parenting behaviors and their baby's behavior. The study is looking for mothers who are between 3 and 24 months postpartum, have concerning symptoms of PTSD, and are currently receiving therapy.
To participate, mothers must not be pregnant, have a significant untreated mental illness, or any serious neurological conditions. They should also be able to understand and consent to the study. If eligible, participants can expect to engage in the neurofeedback training in a supportive outpatient setting, where they will learn techniques to enhance their mental health and parenting skills. This trial is currently recruiting participants in the Greater Detroit area, and it is an opportunity for mothers to work on their well-being while receiving professional support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have clinically concerning symptoms of Post-traumatic Stress Disorder and/or it's dissociative sub-type, as indicated by either a score of 3+ on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) screening measure for PTSD symptoms OR endorsement of 2 or more past-month symptoms of moderate or greater severity on the depersonalization/derealization subscale of the Dissociative Subtype of PTSD Scale (DSPS).
- • Must be between 3-24 months postpartum
- • Must be receiving regular, primarily in-person psychotherapy from a therapist at a clinic in the Greater Detroit area.
- Exclusion Criteria:
- • Are currently pregnant
- • Have a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or substance use disorder) or neurological or pervasive developmental disorder
- • Have a documented history of epilepsy
- • Have ever experienced previous head injury with loss of consciousness
- • Are currently experiencing domestic or intimate partner violence or otherwise state that their current living conditions are unsafe
- • Are currently experiencing psychosis or have been suicidal within the last six months
- • Are currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis
- • Have engaged in self-harming behaviors in the last 3 months requiring medical attention
- • Do not have competence to understand or consent to the study procedures
- • Do not have fluency in written and spoken English
About Wayne State University
Wayne State University, a distinguished public research institution located in Detroit, Michigan, is committed to advancing health and science through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university leverages its robust academic resources and expert faculty to conduct clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Wayne State University fosters a rigorous research environment, ensuring adherence to ethical standards and regulatory compliance while striving to translate research findings into practical applications that benefit diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported